Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2020 | CRISPR and gene editing in clinical practice

Haydar Frangoul • 10 Dec 2020
ASH 2020
General

Haydar Frangoul, MD, Sarah Cannon Blood Cancer Center, Nashville, TN, discusses the challenges of implementing CRISPR and gene editing in clinical practice. Dr Frangoul emphasizes that patients need to have longer follow-up, and the need for more patients to be enrolled on clinical trials. This interview took place during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, 2020

Disclosures

Haydar Frangoul, MD, is a steering committee member at Vertex Pharmaceutical.

More from Haydar Frangoul

Fixed-dose vs weight-based plerixafor in patients with SCD receiving BEAM-101 in the BEACON trial
4:33
Fixed-dose vs weight-based plerixafor in patients with SCD receiving BEAM-101 in the BEACON trial
Haydar Frangoul • 18 Dec 2025
First promising results of exa-cel in pediatric patients with TDT or SCD and recurrent severe VOCs
4:13
First promising results of exa-cel in pediatric patients with TDT or SCD and recurrent severe VOCs
Haydar Frangoul • 18 Dec 2025
Approval of exa-cel for SCD
1:43
Approval of exa-cel for SCD
Haydar Frangoul • 14 Dec 2023
Improvements in HRQoL after exa-cel in patients with transfusion-dependent β-thalassemia
0:48
Improvements in HRQoL after exa-cel in patients with transfusion-dependent β-thalassemia
Haydar Frangoul • 14 Dec 2023

Related Videos

Key principles for implementing AI tools into clinical practice
3:19
Key principles for implementing AI tools into clinical practice
Adrián Mosquera Orgueira • 24 Sep 2026
Current role of AI in hematology/oncology: separating the hype from reality
2:54
Current role of AI in hematology/oncology: separating the hype from reality
Adrián Mosquera Orgueira • 24 Sep 2026
Addressing the risk of over-reliance on AI for clinical decision-making
2:25
Addressing the risk of over-reliance on AI for clinical decision-making
Adrián Mosquera Orgueira • 24 Sep 2026
Telomere dynamics in normal and pathological aging
12:41
Telomere dynamics in normal and pathological aging
Coleman Lindsley • 18 Sep 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals